This is the first reported case of a single patient developing both Takotsubo syndrome and Ogilvie syndrome due to catecholamine excess from a pheochromocytoma.
Answers are grounded in this paper and cite their sources.
Raises awareness for pheochromocytoma in Takotsubo-Ogilvie overlap; extends catecholamine-excess spectrum but leaves optimal management open.
Takotsubo syndrome (TTS) is a transient left ventricle dysfunction usually caused by a stressful trigger (emotional or physical). We report the case of a 77 year-old female patient who presented with TTS caused by a pheochromocytoma, a catecholamine-producing neuroendocrine tumour. Diagnosis was facilitated by acute kidney injury prompting renal ultrasound, recurrence of TTS and symptoms of episodic palpitations, profuse sweating and labile blood pressure. Furthermore, during her hospitalisation the patient also developed an Ogilvie syndrome, an acute colonic pseudo-obstruction, due to the catecholamine-excess. Treatment consisted of betablocker and angiotensin-converting enzyme inhibitor for TTS, neostigmine for Ogilvie syndrome, in combination with alpha-blocker and surgical removal of the tumour after recuperation of left ventricular function and colonic pseudo-obstruction. To our knowledge, this is the first case report of the pathophysiological triad of pheochromocytoma leading to Takotsubo and Ogilvie syndrome in a single patient.
No takes yet. Share an insight, caveat, or question.
Manhaeghe et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: